1,024
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Hyperthermia-driven aberrations of secreted microRNAs in breast cancer in vitro

, , , , , , , , & show all
Pages 630-642 | Received 01 Dec 2015, Accepted 29 Feb 2016, Published online: 05 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lisi Zeng, Quanxing Liao, Xiaohui Zeng, Jiacai Ye, Xianzi Yang, Siyu Zhu, Hongsheng Tang, Gaojie Liu, Weiwen Cui, Shaohua Ma & Shuzhong Cui. (2022) Noncoding RNAs and hyperthermic intraperitoneal chemotherapy in advanced gastric cancer. Bioengineered 13:2, pages 2623-2638.
Read now

Articles from other publishers (2)

Ao-Yu Li, Hui-Ni Xiao, Zi-Yue Zhao, Cheng Xiang, Zhuo-yuan Chen, Ping-xiao Wang, Yu Xia, Bin Yu, Hui Li & Tao Xiao. (2023) Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation. Journal of Cancer Research and Clinical Oncology 149:11, pages 9105-9128.
Crossref
O.I. Mokhonko, V.E. Orel, I.I. Smolanka (Sr.)L.A. Syvak, A.D. Loboda, I.V. Dosenko, A.O. Lyashenko, I.I. Smolanka (Jr.)O.Yu. Rykhalskyi, V.B. Orel, O.I. Dasyukevich, T.Ye. Tarasenko & S.I. Vovyanko. (2021) Inductive hyperthermia planning for patients with breast cancer metastasis to lymph nodes. Nuclear Physics and Atomic Energy 22:3, pages 312-317.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.